Your session is about to expire
← Back to Search
Particle Embolic
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
N/A
Waitlist Available
Led By Ziv J Haskal, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this project is to evaluate the safety, efficacy, and feasibility of performing prostatic artery embolization (PAE) using endovascular techniques and particle embolics in men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
Eligible Conditions
- Urinary Tract Infection
- Benign Prostatic Hyperplasia
- Skin Hyperplasia
- Urological Disorders
- Benign prostatic hyperplasia
- Enlarged Prostate
- Prostate Enlargement
- Hyperplasia
- Genitourinary Diseases
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinical improvement in Lower Urinary Tract Symptoms (LUTS)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Embozene MicrospheresExperimental Treatment1 Intervention
Embozene Microspheres are spherical particles consisting of a hydrogel core and a poly nanocoat that will be used during study procedure, Prostatic Artery Embolization (PAE) to reduce or eliminate bloodflow to the prostate.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Embozene Microspheres
2014
N/A
~300
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
782 Previous Clinical Trials
1,315,652 Total Patients Enrolled
Siemens Medical SolutionsIndustry Sponsor
24 Previous Clinical Trials
3,678 Total Patients Enrolled
Ziv J Haskal, MDPrincipal InvestigatorProfessor of Radiology